These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5117839)
1. [Organization of an otorhinolaryngologic service to patients with tuberculosis]. Dadamukhamedov A Probl Tuberk; 1971; 49(6):89-90. PubMed ID: 5117839 [No Abstract] [Full Text] [Related]
2. [Tuberculosis in otorhinolaryngology and results of its treatment]. Cvetnić V Plucne Bolesti Tuberk; 1971; 23(2):216-24. PubMed ID: 5140880 [No Abstract] [Full Text] [Related]
4. [Chlormethylencycline in otorhinolaryngologic diseases. (Clinical trials)]. Di Brino M; Baldiserri L Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):329-41. PubMed ID: 5621897 [No Abstract] [Full Text] [Related]
5. [Tuberculosis in otorhinolaryngology]. Ilić C; Stefanović P; Krejović B; Stanisavljević B Med Glas; 1972 Aug; 26(8):277-80. PubMed ID: 4657430 [No Abstract] [Full Text] [Related]
6. [Therapy with propicillin juice in infants and childhood]. Nohlen A Dtsch Med J; 1967 Apr; 18(8):242-4. PubMed ID: 4967292 [No Abstract] [Full Text] [Related]
8. [Importance of monitoring antibiotic drugs in otorhinolaryngologic therapy]. Pokrajac M; Dotlić R Srp Arh Celok Lek; 2002; 130 Suppl 1():49-52. PubMed ID: 12395465 [No Abstract] [Full Text] [Related]
9. [A new molecule with anti-infective activity in otorhinolaryngology]. Martin H J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 Nov; 27(9):659-62. PubMed ID: 153949 [No Abstract] [Full Text] [Related]
10. [Controlled studies of the acivity of Xanthocycline, in aosol and oral administration, in some otorhinolaryngological bacterial diseases]. Lipozencic M; Petric K; Radej I; Trubic I Minerva Otorinolaringol; 1969; 19(5):285-94. PubMed ID: 5380543 [No Abstract] [Full Text] [Related]
11. The aminoglycosides. Tuazon C Ear Nose Throat J; 1981 May; 60(5):233-8. PubMed ID: 7227273 [No Abstract] [Full Text] [Related]
12. [Kitasamycin in otorhinolaryngology]. Bourdial J; Natali R Sem Ther; 1964 Oct; 40(8):494-5. PubMed ID: 5878574 [No Abstract] [Full Text] [Related]
13. [The genetic basis of the variability of germs in otorhinolaryngologic diseases. I. The appearance of resistance to antibiotics in bacteria]. Midan F; Lengyel Z; Dumitrescu M Otorinolaringologie; 1968; 13(4):315-24. PubMed ID: 5720732 [No Abstract] [Full Text] [Related]
14. [Best use of drugs. B. Use of antibiotics. 10/ Otorhinolaryngologic infections]. Legat C; Mandy B; Woronoff-Lemsi MC Soins; 2003 Jun; (676):55-6. PubMed ID: 12852278 [No Abstract] [Full Text] [Related]
15. Treatment of otorrhea associated with tubes or perforations. Poole MD Ear Nose Throat J; 1993 Mar; 72(3):225-6. PubMed ID: 8482269 [No Abstract] [Full Text] [Related]
16. [Drug therapy in otorhinolaryngology: specificity in pediatrics--chemotherapy]. Fujii Y Nihon Jibiinkoka Gakkai Kaiho; 1972 Dec; 75(12):1456-8. PubMed ID: 4675765 [No Abstract] [Full Text] [Related]
17. [The genetic basis of the variability of germs in otorhinolaryngologic diseases. II. Appearance of resistance to antibiotics due to recombinations]. Lengyel Z; Midan F; Dumitrescu M Otorinolaringologie; 1968; 13(4):325-36. PubMed ID: 5720733 [No Abstract] [Full Text] [Related]